ABSTRACT
Prognosis of metastatic breast cancer is very poor which urges the necessity to develop novel potential drug candidates. We assessed two compounds with tri-aryl structures (A and B) for their potency to reduce primary breast tumor growth and lung metastasis in 4T1 mice model. MTT assay, 4T1 mammary mouse model, and immunohistochemistry experiments were used in this study. In-vitro results exhibited an anti-proliferative effect for compounds A and B towards MDA-MB-231 cancer cells. Our in-vivo results displayed that administered compounds A and B could suppress the size of the primary tumor and the number of lung metastatic foci in 4T1 BALB/c mice model. Histopathological analysis revealed that treatment of both compounds resulted in necrosis. Our findings provide new evidence that compound B may be promising for slowing the growth of tumor along with metastatic foci via COX-2 independent pathway.
ABSTRACT
The behavior of dithizone (DTZ), an easily available dye has been studied for the first time in chromogenic sensing of CN(-) as an anionic species and for Co(2+) as a cationic species in DMSO/H2O media. So employing DTZ an efficient colorimetric chemosensor was afforded with a chromogenic selectivity for Co(2+) over other cations with detection limit of 0.04 µmol L(-1). The complex of Co(2+) with DTZ also displayed ability to detect up to 0.43 µmol L(-1) CN(-) (K(+) salts) among other competing anions through a fast response time of less than 30s which is much lower than most recently reported chromogenic probes. The linear dynamic ranges for the determination of Co(2+) and CN(-) were 0.3-4.4 and 3.3-58.6 µmol L(-1) respectively. This method could have potential application in a variety of cases requiring rapid and accurate analysis of Co(2+) and CN(-) for human serum and water samples.
